Skip to content
Search

Latest Stories

Pharmacy leaders call for reassurance of community pharmacy's inclusion in NHS workforce plan

Pharmacy leaders have called for reassurance that the workforce plan, expected by April 2023, will cover the entirety of the pharmacy workforce across the health service, including in community pharmacies.


A joint letter has been signed by representatives from 14 pharmacy organisations which highlights that with continued pressures on services, it is more important than ever to support the pharmacy workforce so that the staff needed to deliver patient care now and into the future can be recruited, trained and retained.

Mark Koziol, Pharmacists' Defence Association (PDA) Chairman said: “Our pharmacist members practise across the entire health system and have the potential to do far more to help patients and improve public health, but they can only do so safely if they are in appropriately staffed workplaces. This is a workforce issue, so it is important that the Government works with representatives of the pharmacist workforce, and of their employers, to get a suitably agreed plan in place.”

Thorrun Govind, English Pharmacy Board Chair, Royal Pharmaceutical Society (RPS), said: “It will be crucial to use the skills of all our health professions to support the NHS recovery, reduce health inequalities, manage the growing cost of long-term conditions, and deliver best value from medicines.

"Pharmacists are increasingly working across care settings and as such the whole of the pharmacy workforce must be included in the Government’s upcoming long-term workforce plan and supported by investment in education and training.

"Pharmacy teams across the health service are under enormous pressure and as well as support for frontline staff now, the workforce plan must also look to the future and how we can make the most of the next generation of pharmacist independent prescribers to enhance patient care."

The letter was co-signed by:

  • Dr Leyla Hannbeck, Chief Executive, Association of Independent Multiple Pharmacies
  • Claire Steele, President, Association of Pharmacy Technicians UK
  • Joseph Williams, Chair, British Oncology Pharmacy Association
  • Priyanka Patel, President, British Pharmaceutical Students’ Association
  • Roz Gittins, President, College of Mental Health Pharmacy
  • Malcolm Harrison, Chief Executive, Company Chemists’ Association
  • Nathan Burley, President, Guild of Healthcare Pharmacists
  • Mark Lyonette, Chief Executive, National Pharmacy Association
  • Janet Morrison OBE, Chief Executive, Pharmaceutical Services Negotiating Committee
  • Mark Koziol, Chairman, Pharmacists’ Defence Association
  • Prof Katie Maddock, Chair, Pharmacy Schools Council
  • Dr Graham Stretch, President, Primary Care Pharmacy Association
  • Thorrun Govind, English Pharmacy Board Chair, Royal Pharmaceutical Society
  • Mohamed Rahman, Chair, UK Clinical Pharmacy Association

More For You

Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Keep ReadingShow less
NHS expands pharmacogenomics trial to enhance personalised medicine
The NHS is poised to take a bold step towards personalised medicine (gettyimages)

Personalised medicine: NHS expands pharmacogenomics trial across England

With this study, the NHS aims to address barriers to the national implementation of pharmacogenomics, making personalised medicine to become standard practice

A national pharmacogenomics research study is making significant progress towards adopting personalised medicine within the NHS.

Keep ReadingShow less
Integrating clinical pharmacists into general practice significantly reduced medicine costs, opioid prescriptions, and anxiolytic use
The growing presence of clinical pharmacists in GP practices is driving improvements in in quality of prescribing and patient safety (gettyimages)

Clinical pharmacists in GP practices improve prescribing quality, patient safety

Integrating clinical pharmacists into general practice significantly reduced medicine costs, opioid prescriptions, and anxiolytic use

The growing presence of clinical pharmacists in GP practices is driving improvements in in quality of prescribing and patient safety in primary care settings, a new study has revealed.

Keep ReadingShow less
India aims to become a top five pharma exporter by 2047
India is the world’s largest supplier of generic medicines (gettyimages)

India’s pharma exports expected to cross £280 billion by 2047

India aims to become a top five pharma exporter by expanding into specialty generics, biosimilars and innovative products

India’s pharmaceutical exports are projected to grow from $27 billion (£21.73 billion) in 2023 to $65 billion (£ 52.31 billion) by 2030, with the potential to reach an estimated $350 billion (£281.72 billion) by 2047, according to a new industry report.

Keep ReadingShow less